NanoViricides Inc.
NNVCNanoViricides Inc. (NNVC) is a biotechnology company focused on developing nanotechnology-based antiviral drugs. The company's approach involves designing targeted nanomedicines to neutralize viruses and treat viral infections, including emerging and persistent viral threats. NanoViricides aims to create broad-spectrum antivirals that can address a wide range of viral diseases.
Company News
The article discusses two small-cap biotech companies with high-risk, high-potential investment opportunities: Mainz Biomed and NanoViricides. Both companies are developing innovative medical technologies but face significant financial challenges and are pre-revenue.
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavio...
SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The I...
UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market trading. Credit Suisse raised the price target for uniQure N.V. (NASDAQ: QURE) from $51 to $55. Credit Suisse analyst Judah Frommer maintained an Outp...
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash. Onion Global Limited (NYSE: OG) jumped 90.6% to close at $0.7624 on Thursday. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares...
